Everyday Health on MSN
10 Tips for Making RA Self-Injections Easier
With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.
This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more ...
Best Life on MSN
6 Ways the New Wegovy Pill Compares to the Shot for Weight Loss
How does the new Wegovy pill compare to the shot for weight loss? Here are six ways, from side effects to absorption.
Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company's supplemental Biologics License Application (sBLA) for HYMPAVZI® ...
Iowa and Indiana have recently introduced legislation that would establish new registration and licensure requirements for medical spas. Iowa ...
MedPage Today on MSN
Case study: Do these symptoms really indicate a stroke?
Getting to the bottom of the cause in this 29-year-old woman illustrates the diagnostic co ...
Everyday Health on MSN
SCIg for primary immunodeficiency: Troubleshooting swelling, redness, and pain at the infusion site
Discover tips for managing swelling, redness, and pain at subcutaneous immunoglobulin (SCIg) infusion sites for primary ...
AllAfrica on MSN
Twice-Yearly Lenacapavir Injection for HIV Prevention in Nigeria - the Real Test Is Access
On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.
In fact, the recent months have included some of the more significant achievements in Arrowhead's history. First, on November ...
Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 weeks, according to data published in Arthritis & Rheumatology.“As a ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of liver disease worldwide, affecting one in three people.1,2 The inflammatory form of MASLD, namely ...
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results